KRAS and lung carcinoma: However, comparison of collagen isoform mRNA expression between mutant EGFR and KRAS LUAD and LUSC TCGA samples showed no significant difference in collagen gene expression between the mutant subtypes (Supplementary Fig. 11e and f), suggesting another mechanism of immune suppression in mutant EGFR lung cancers.